Learn how you can invest in the success of SegueTx-Pancreatic Cancer, LLC.
Drug repurposing is reported to be faster, involve less risk and is more cost effective compared traditional novel drug discovery companies, as reported in this article. In fact, drug repurposing currently commands 25% of all pharmaceutical sales.
Upon request, we will supply potential investors, partners and collaborators with an executive overview that discusses the investment opportunity, business plan and model, and current milestones for SegueTx-Pancreatic Cancer, LLC. The company is looking to close the seed round of financing at this time.